Tag: Akili

Biotech, Industry

Akili digital therapeutic shows promise in lupus patients

July 15, 2022

Via: Pharmaphorum

The PureTech group company – which scored the first FDA and EMA approvals for a DTx for attention-deficit hyperactivity disorder (ADHD) – is developing AKL-T01 to tackle cognitive impairments that can affect people with SLE. Cognitive dysfunction occurs in between […]